Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Richard Finkel

Neurology with Special Qualifications in Child Neurology Memphis, TN Medical Doctor

NPI 1073547741 CMS profile 1105661

262 Danny Thomas Pl, Memphis, TN 38105

Open in the dashboard

General payments

$352,588

438 records reported · program years 2019–2025

Research payments

$33,102

Paid to them · 38 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$3,324,833 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Richard Finkel of Memphis, TN is reported in the CMS Open Payments database as having received $352,588 across 438 general payments and $33,102 in research payments paid to them. Separately, studies naming them as principal investigator received $3,324,833 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Neurology with Special Qualifications in Child Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $79,183 34
2025 Research $13,450 10
2024 General $13,275 13
2024 Research $10,321 10
2023 General $61,144 51
2023 Research $354 1
2022 General $39,635 81
2022 Research $845 1
2021 General $47,608 46
2021 Research $2,385 6
2020 General $54,106 81
2020 Research $5,746 10
2019 General $57,638 132

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Richard Finkel
  • Neurology with Special Qualifications in Child Neurology median
  • Middle half of Neurology with Special Qualifications in Child Neurology
  • National median

In program year 2025, general payments to Richard Finkel were reported at $79,183. Among 1,228 Neurology with Special Qualifications in Child Neurology profiles paid that year, the median was $276 and the middle half received between $87 and $1,522.

Show as a table
Year Richard Finkel Neurology with Special Qualifications in Child Neurology median Middle half National median
2019 $57,638 $262 $68–$1,313 $163
2020 $54,106 $188 $46–$1,222 $114
2021 $47,608 $183 $45–$1,356 $132
2022 $39,635 $229 $72–$1,177 $149
2023 $61,144 $269 $93–$1,195 $160
2024 $13,275 $300 $98–$1,428 $164
2025 $79,183 $276 $87–$1,522 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AveXis $127,725 294 payments
  2. Sarepta Therapeutics, Inc. $62,002 49 payments
  3. F. Hoffmann-La Roche AG $52,471 29 payments
  4. Genentech USA, Inc. $28,339 15 payments
  5. Biogen, Inc. $27,185 15 payments
  6. Novartis Pharma AG $25,486 4 payments
  7. Novartis Pharmaceuticals Corporation $19,772 8 payments
  8. Roche Products Limited $8,717 11 payments
  9. Genentech, Inc. $773 8 payments
  10. LivaNova USA, Inc. $44 1 payment
  11. Other $74 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $171,930 43 payments
  2. Education $72,891 217 payments
  3. Travel and Lodging $43,179 46 payments
  4. Honoraria $34,792 4 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $24,159 73 payments
  6. Food and Beverage $5,638 55 payments
Products named General payments · program years 2019–2025
  1. ZOLGENSMA Gene Therapy $127,725 294 payments
  2. Non-Covered Product $38,587 30 payments
  3. Evrysdi $32,388 24 payments
  4. ZOLGENSMA Neurology $32,286 5 payments
  5. SPINRAZA $21,281 9 payments
  6. Elevidys $14,597 13 payments
  7. Exondys 51 $128 1 payment
  8. VNS Therapy $44 1 payment
  9. FYCOMPA $26 1 payment
  10. Epidiolex $22 1 payment
  11. Other $49 4 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. F. Hoffmann-La Roche AG $16,397 34 payments
  2. Novartis Pharmaceuticals Corporation $8,745 1 payment
  3. AveXis $7,549 2 payments
  4. Novartis Pharma AG $411 1 payment

Records

476 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology with Special Qualifications in Child Neurology in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record